Mucus hypersecretion in chronic obstructive pulmonary disease and its treatment

BK Shah, B Singh, Y Wang, S Xie… - Mediators of …, 2023 - Wiley Online Library
Most patients diagnosed with chronic obstructive pulmonary disease (COPD) present with
hallmark features of airway mucus hypersecretion, including cough and expectoration …

Medicinal chemistry strategies to extend duration of action of inhaled drugs for intracellular targets

KE Samy, C Gampe - Bioorganic & Medicinal Chemistry Letters, 2022 - Elsevier
Prolonging duration of action of inhaled drugs is a challenging endeavor and guidance for
medicinal chemistry teams is very limited, particularly if the site of action is intracellular …

[HTML][HTML] 2-Phenethylamines in medicinal chemistry: A review

CT Nieto, A Manchado, L Belda, D Diez, NM Garrido - Molecules, 2023 - mdpi.com
A concise review covering updated presence and role of 2-phenethylamines in medicinal
chemistry is presented. Open-chain, flexible alicyclic amine derivatives of this motif are …

Bronchodilating drugs for chronic obstructive pulmonary disease: current status and future trends

P Montuschi, G Ciabattoni - Journal of medicinal chemistry, 2015 - ACS Publications
Inhaled bronchodilators, including long-acting muscarinic receptor antagonists (LAMA) and
long-acting β2-adrenoreceptor agonists (LABA), are the mainstay of pharmacological …

Mechanisms of glucocorticoid action and insensitivity in airways disease

C Boardman, L Chachi, A Gavrila, CR Keenan… - Pulmonary …, 2014 - Elsevier
Glucocorticoids are the mainstay for the treatment of chronic inflammatory diseases
including asthma and chronic obstructive pulmonary disease (COPD). However, it has been …

Review of drug development guidance to treat chronic obstructive pulmonary disease: US and EU perspectives

A van Haarst, L McGarvey… - Clinical Pharmacology & …, 2019 - Wiley Online Library
Chronic obstructive pulmonary disease (COPD) remains a leading cause of death
worldwide, yet only one new drug class has been approved in the last decade. However …

Pharmacological treatment of chronic obstructive pulmonary disease: from evidence-based medicine to phenotyping

P Montuschi, M Malerba, G Santini, M Miravitlles - Drug discovery today, 2014 - Elsevier
Highlights•Several phenotypes characterize chronic obstructive pulmonary disease
(COPD).•Response to pharmacological treatment in COPD is highly variable.•Guidelines …

An evolving perspective on novel modified release drug delivery systems for inhalational therapy

T Hye, SM Moinuddin, T Sarkar, T Nguyen… - Expert opinion on …, 2023 - Taylor & Francis
Introduction Drugs delivered via the lungs are predominantly used to treat various
respiratory disorders, including asthma, chronic obstructive pulmonary diseases, respiratory …

Breath analysis in real time by mass spectrometry in chronic obstructive pulmonary disease

P Martinez-Lozano Sinues, L Meier, C Berchtold… - Respiration, 2014 - karger.com
Background: It has been suggested that exhaled breath contains relevant information on
health status. Objectives: We hypothesized that a novel mass spectrometry (MS) technique …

Adrenal-derived stress hormones modulate ozone-induced lung injury and inflammation

A Henriquez, J House, DB Miller, SJ Snow… - Toxicology and applied …, 2017 - Elsevier
Ozone-induced systemic effects are modulated through activation of the neuro-hormonal
stress response pathway. Adrenal demedullation (DEMED) or bilateral total adrenalectomy …